8i Acquisition 2 filed an updated investor presentation on its proposed merger with Singapore-based EUDA Health Limited, a digital health platform.
The two parties last month amended their share purchase agreement to reduce the consideration payable by the SPAC and limit the earn-out payment available to the seller of EUDA Health.
8i and EUDA Health agreed to revise the deal, resulting in a pro forma enterprise value (assuming no redemption at closing) for the combined company of $172 million. The deal had an enterprise value of $583 million when announced in April.
EUDA Health also revised its financial projections for 2022 to 2026 to account for the delays caused by the ongoing COVID-19 restrictions in some overseas markets, such as Indonesia and India, where EUDA Health has plans to expand. Read more.
